Serum Carnitine Levels in Centenarians
- 6 Downloads
Objective and Study Participants: We evaluated serum carnitine concentrations in a group of 17 centenarians (six males, 11 females: mean age 102.35 ±2.21 years), and compared them with a control group that comprised 20 elderly volunteers (age range: 66 to 75 years).
Results: The mean serum carnitine level in the centenarian group was 8.99 ±5.1 mg/L compared with 7.71 ±0.92 mg/L in the control group (p = NS). Serum carnitine levels were not significantly correlated with lipid pattern, kidney function, daily activity, body mass index and daily diet in the centenarians. Analysis of the lipid pattern revealed that the mean serum total cholesterol, low density lipoprotein (LDL) cholesterol, apoprotein B100 and triglyceride concentrations were higher in the controls than in the centenarians (p = 0.01 for total cholesterol, LDL cholesterol, and apoprotein B100; p = 0.05 for triglycerides). High density lipoprotein (HDL) cholesterol and apoprotein A levels were significantly lower in the controls than in the centenarians (p = 0.01). We postulated that an endogenous synthesis is responsible for the increased serum carnitine levels observed in the centenarians.
Conclusion: In our study series, the association between a good lipid profile and elevated serum carnitine levels, although nonsignificant, might be considered an important factor in achieving longevity.
KeywordsAdis International Limited Carnitine High Density Lipoprotein Cholesterol Clin Drug Invest Carnitine Deficiency
Unable to display preview. Download preview PDF.
- 3.Morrisset JD, Pownall HJ, Gotto AM. Bovine serum albumin. Study of the fatty acid and steroid binding sites using spinlabelled lipids. J Biol Chem 1975; 250: 24–8Google Scholar
- 5.Visioli O, Pasini E, De Giuli F, et al. Molecular mechanism of action of L-carnitine in treatment of myocardial disorders at the experimental level. In: Ferrari R, Di Mauro S, Sherwood G, editors. L-carnitine and its role in medicine: from function to therapy. London: Academic Press, 1992: 237–59Google Scholar
- 9.Pola P, Savi L, Grilli M, et al. Carnitine in the therapy of dyslipidemic patients. Curr Ther Res 1980; 27(2): 208–16Google Scholar
- 11.Pola P, Tondi P, Dal Lago A, et al. Statistical evaluation of long-term l-carnitine therapy in hyperlipoproteinaemias. Drugs Exp Clin Res 1983; 9(12): 925–34Google Scholar
- 12.Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press, 1974; 4: 1831–5Google Scholar
- 13.Lopez-Virella MF, Stone P, Ellis S, et al. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882–4Google Scholar
- 15.Ordovas JM, Peterson JP, Santaniello P, et al. Enzyme linked immunosorbent assay for human plasma apolipoprotein. Lipid Res 1987; 28: 1216–24Google Scholar
- 16.Wieland OH et al. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 3rd ed. Weinheim, Deerfield Beach, Florida, USA: VCH Verlagegesellschaft, Vol. in: 481–88Google Scholar
- 27.Stefanutti C, Vivenzio A, Lucani G, et al. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia. Clin Ther 1998; 149: 115–9Google Scholar